UA67741C2 - Солюбілізовані композиції сертраліну - Google Patents

Солюбілізовані композиції сертраліну Download PDF

Info

Publication number
UA67741C2
UA67741C2 UA99116391A UA99116391A UA67741C2 UA 67741 C2 UA67741 C2 UA 67741C2 UA 99116391 A UA99116391 A UA 99116391A UA 99116391 A UA99116391 A UA 99116391A UA 67741 C2 UA67741 C2 UA 67741C2
Authority
UA
Ukraine
Prior art keywords
sertraline
solubilizing agent
item
composition
composition according
Prior art date
Application number
UA99116391A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Дуейн Томас Фрізен
Скотт Макс Хербіг
Раві Майсор Шенкер
Джеймс Блеер Вест
Original Assignee
Пфайзер Продактс Інк.
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA67741(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пфайзер Продактс Інк., Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Інк.
Publication of UA67741C2 publication Critical patent/UA67741C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
UA99116391A 1997-07-01 1998-06-15 Солюбілізовані композиції сертраліну UA67741C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions

Publications (1)

Publication Number Publication Date
UA67741C2 true UA67741C2 (uk) 2004-07-15

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99116391A UA67741C2 (uk) 1997-07-01 1998-06-15 Солюбілізовані композиції сертраліну

Country Status (34)

Country Link
EP (1) EP0999829A1 (ja)
JP (1) JP2000514100A (ja)
KR (1) KR100366373B1 (ja)
CN (1) CN1261794A (ja)
AP (1) AP1192A (ja)
AR (3) AR015917A1 (ja)
AU (1) AU742535B2 (ja)
BG (1) BG103918A (ja)
BR (1) BR9810739A (ja)
CA (1) CA2290974C (ja)
CO (1) CO4940495A1 (ja)
DZ (1) DZ2548A1 (ja)
EA (1) EA002481B1 (ja)
HN (1) HN1998000102A (ja)
HR (1) HRP980377A2 (ja)
HU (1) HUP0002236A3 (ja)
ID (1) ID23429A (ja)
IL (1) IL133076A (ja)
IS (1) IS5260A (ja)
MA (1) MA24587A1 (ja)
NO (1) NO996520L (ja)
OA (1) OA11243A (ja)
PA (1) PA8454301A1 (ja)
PE (1) PE97199A1 (ja)
PL (1) PL337804A1 (ja)
SK (1) SK181099A3 (ja)
TN (1) TNSN98124A1 (ja)
TR (1) TR199903297T2 (ja)
TW (1) TW550087B (ja)
UA (1) UA67741C2 (ja)
UY (1) UY25071A1 (ja)
WO (1) WO1999001120A1 (ja)
YU (1) YU68299A (ja)
ZA (1) ZA985708B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3227A1 (fr) 1999-12-23 2001-07-05 Pfizer Prod Inc Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
MXPA03001771A (es) 2000-08-30 2003-06-04 Pfizer Prod Inc Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
CN101631593B (zh) * 2007-03-12 2014-08-13 帝斯曼知识产权资产管理有限公司 化妆品组合物
BR112012003592B8 (pt) 2009-08-19 2021-05-25 Eisai R&D Man Co Ltd composição farmacêutica contendo derivado de quinolina
US20130035344A1 (en) * 2009-12-29 2013-02-07 Kowa Co., Ltd. Pharmaceutical composition for oral administration
JPWO2011081117A1 (ja) * 2009-12-29 2013-05-09 興和株式会社 経口投与用固形医薬組成物
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺
CN114894736B (zh) * 2022-05-20 2025-03-21 中化地质矿山总局地质研究院 一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
ATE96999T1 (de) * 1989-08-30 1993-11-15 Pfizer Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
IL133076A (en) 2003-12-10
CO4940495A1 (es) 2000-07-24
ZA985708B (en) 2000-01-10
CA2290974A1 (en) 1999-01-14
PA8454301A1 (es) 2000-09-29
BR9810739A (pt) 2000-09-12
YU68299A (sh) 2002-06-19
ID23429A (id) 2000-04-20
NO996520D0 (no) 1999-12-28
AP1192A (en) 2003-07-23
SK181099A3 (en) 2000-07-11
BG103918A (en) 2000-07-31
EA199900962A1 (ru) 2000-08-28
AR040279A2 (es) 2005-03-23
JP2000514100A (ja) 2000-10-24
AU7544898A (en) 1999-01-25
MA24587A1 (fr) 1998-12-31
AR040280A2 (es) 2005-03-23
KR20010013365A (ko) 2001-02-26
AR015917A1 (es) 2001-05-30
EA002481B1 (ru) 2002-06-27
OA11243A (en) 2003-07-24
HUP0002236A3 (en) 2003-12-29
KR100366373B1 (ko) 2003-01-14
TNSN98124A1 (fr) 2005-03-15
AU742535B2 (en) 2002-01-03
DZ2548A1 (fr) 2003-02-08
PL337804A1 (en) 2000-09-11
EP0999829A1 (en) 2000-05-17
NO996520L (no) 2000-02-29
HRP980377A2 (en) 1999-04-30
HN1998000102A (es) 1999-01-08
HUP0002236A2 (hu) 2003-08-28
TW550087B (en) 2003-09-01
AP9801280A0 (en) 1998-06-30
CA2290974C (en) 2004-04-27
IL133076A0 (en) 2001-03-19
TR199903297T2 (xx) 2000-07-21
WO1999001120A1 (en) 1999-01-14
UY25071A1 (es) 2000-12-29
IS5260A (is) 1999-11-19
PE97199A1 (es) 1999-10-05
CN1261794A (zh) 2000-08-02

Similar Documents

Publication Publication Date Title
EP0533297B1 (en) Controlled-release pharmaceutical formulations
KR0140985B1 (ko) 장기 작용성 제제에 유용한 약물 방출 조절용 피복물질
ES2314227T3 (es) Formulacion farmaceutica oral en forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxilicina.
JP2002501016A (ja) 新しい投薬形態
Yadav et al. Dual coating of swellable and rupturable polymers on Glipizide loaded MCC pellets for pulsatile delivery: Formulation design and in vitro evaluation
SK8252001A3 (en) Controlled release formulation of divalproex sodium
RU2181043C2 (ru) Фармацевтическая композиция для орального введения с модифицированным высвобождением, содержащая 5-аск, и способ лечения кишечных заболеваний
US20090181089A1 (en) PH-Controlled Pulsatile Delivery System, Methods for Preparation and Use Thereof
USRE42748E1 (en) Oral DTPA for radionuclide chelation
ES2852899T3 (es) Formulaciones estabilizadas de molindona
AU742535B2 (en) Solubilized sertraline compositions
ES2321908T3 (es) Preparaciones farmaceuticas de liberacion prolongada independientemente del ph.
PT1618873E (pt) Grânulos para libertação controlada de tamsulosina, que contém alginato.
ES2896150T3 (es) Composiciones líquidas de liberación prolongada de guaifenesina
US20040208926A1 (en) Solubilized sertraline compositions
NZ501250A (en) Solubilized sertraline compositions
MXPA99012101A (en) Solubilized sertraline compositions
RU2412694C2 (ru) pH-КОНТРОЛИРУЕМЫЕ СИСТЕМЫ ИМПУЛЬСНОЙ ДОСТАВКИ, МЕТОДЫ ПОЛУЧЕНИЯ И ИХ ИСПОЛЬЗОВАНИЯ
KR950007097B1 (ko) 서방성 캡슐
TR2023014802T2 (tr) Mesalazi̇n enteri̇k tablet formülasyon bi̇leşi̇mi̇
CA2578806A1 (en) Oral formulations of paricalcitol